This site is intended for U.S. healthcare professionals.
XYNTHA SOLOFUSE can help your patients live actively.
XYNTHA is indicated for bleed treatment, control, and protection in adults and children with hemophilia A
** This is an optional area where footnotes can live.
Across clinical trials of previously treated patients (PTPs), XYNTHA has demonstrated a low rate of inhibitor formation
** This is an optional area where footnotes can live.
XYNTHA SOLOFUSE comes in a travel-ready kit and keeps your patients ready to infuse on the go
** This is an optional area where footnotes can live.
** This is an optional area where footnotes can live.
XYNTHA SOLOFUSE. Prescribing information. Pfizer Inc.; 2020.
XYNTHA® Antihemophilic Factor (Recombinant) is indicated in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, for perioperative management, and for routine prophylaxis to reduce the frequency of bleeding episodes.
XYNTHA is not indicated in patients with von Willebrand’s disease.
Please see full Prescribing Information for XYNTHA and XYNTHA SOLOFUSE.
XYNTHA® Antihemophilic Factor (Recombinant) is indicated in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, for perioperative management, and for routine prophylaxis to reduce the frequency of bleeding episodes.
XYNTHA is not indicated in patients with von Willebrand’s disease.
Please see full Prescribing Information for XYNTHA and XYNTHA SOLOFUSE.
Please see full Prescribing Information for XYNTHA and XYNTHA SOLOFUSE.
OK. We'll need you to sign in before we can determine if you are aligned with a sales representative.
If you select 'Yes', you will be required to enter your username and password in the sign-in form that will appear over this window.
Would you like to sign in now?